Literature DB >> 23074606

Cardiovascular effects of saffron: an evidence-based review.

Maryam Kamalipour1, Shahin Akhondzadeh.   

Abstract

Herbal medicine can be a valuable source of assistance for traditional medicine. There are a number of herbs that can be used in conjunction with modern medicine. Herbs can also be taken to aid recovery from serious diseases. Although one should never aim to treat diseases such as cardiovascular disease solely with herbal medicine, the value of herbs used in tandem with modern medicine cannot be ignored. Saffron has been reported to help lower cholesterol and keep cholesterol levels healthy. Animal studies have shown saffron to lower cholesterol by as much as 50%. Saffron has antioxidant properties; it is, therefore, helpful in maintaining healthy arteries and blood vessels. Saffron is also known to have anti-inflammatory properties, which are beneficial to cardiovascular health. The people of Mediterranean countries, where saffron use is common, have lower than normal incidence of heart diseases. From saffron's cholesterol lowering benefits to its anti inflammatory properties, saffron may be one of the best supplements for cardiac health. This paper reviews the studies regarding the beneficial effects of saffron in cardiovascular health.

Entities:  

Keywords:  Anti-inflammatory agents; Cardiovascular agents; Crocus; Lipid regulating agents; non-steriodal

Year:  2011        PMID: 23074606      PMCID: PMC3466873     

Source DB:  PubMed          Journal:  J Tehran Heart Cent        ISSN: 1735-5370


Introduction

The role of alternative medicine in general and phytotherapy in various diseases in particular has been of extreme interest to various scientific and non-scientific communities throughout the world. Phytotherapy is broadly defined as the use of natural therapeutic agents derived from plants or crude herbal drugs. Herbal medicine has a long and respected history and holds a valuable place in the treatment of cardiovascular diseases as well as the vast majority of health problems. Utilizing the leaves, flowers, stems, berries, and roots of plants to both prevent and treat illness, herbal medicine not only helps to alleviate symptoms but also helps to treat the underlying problem, as well as strengthen the overall functioning of a particular organ or body system.1, 2 Cardiovascular diseases are now considered a major cause of mortality not only in the developed world but also in the developing countries. In the age of genomics, nanotechnology, and proteomics, cardiovascular diseases continue to remain a major challenge to therapeutically manage; and the search for a viable evidence-based alternative continues. Saffron (Crocis sativus) is a spice derived from the flower of the saffron crocus (Crocus sativus), a species of crocus in the family Iridaceae. The flower has three stigmas, which are the distal ends of the plant’s carpels. Together with its style, the stalk connecting the stigmas to the rest of the plant, these components are often dried and used in cooking as a seasoning and coloring agent. Saffron, which has for decades been the world’s most expensive spice by weight, is native to Iran; it was first cultivated in the Persian Empire.2, 3 Saffron is characterized by a bitter taste and an iodoform- or hay-like fragrance; these are caused by the chemicals picrocrocin and safranal. It also contains a carotenoid dye, crocin, which gives food a rich golden-yellow hue. These traits make saffron a much-sought ingredient in many foods worldwide. Saffron also has medicinal applications.3, 4 Saffron tastes bitter and contributes a luminous yellow-orange coloring to foods. Because of the unusual taste and coloring it adds to foods, saffron is widely used in Persian, Arab, Central Asian, European, Indian, Moroccan, and Cornish cuisines. Confectionaries and liquors also often include saffron. Medicinally, saffron has a long history as part of traditional healing; modern medicine has also discovered saffron as having anticarcinogenic (cancer-suppressing), anti-mutagenic (mutation-preventing), immuno-modulating, and antioxidant-like properties. Saffron has also been used as a fabric dye, particularly in China and India, and in perfumery.1, 2 Recent studies have shown the beneficial effects of saffron in depression, premenstrual syndrome (PMS), and Alzheimer’s Disease.3–9

Saffron and Heart Disease Protection

Antioxidants in saffron tea can reduce the risk of cardiovascular diseases. The flavonoids, especially lycopene, found in saffron can provide added protection. A clinical trial at the Department of Medicine and Indigenous Drug Research Center showed positive effects of saffron on cardiovascular diseases.10 The study involved 20 participants, including 10 with heart diseases. According to the Indian Journal of Medical Sciences, all the participants showed improved health, but those with cardiovascular diseases showed more progress. In addition, saffron has been found to be the richest source of riboflavin.1, 2 Due to the presence of crocetin, it indirectly helps to reduce cholesterol level in the blood and severity of atherosclerosis, thus reducing the chances of heart attacks. It may be one of the prime reasons that in Spain, where Saffron is consumed liberally, the incidence of cardiovascular diseases is quite low. The crocetin present in saffron is found to increase the yield of antibiotics.11 Two compounds of safranal are supposed to increase antibacterial and antiviral physiological activity in the body.12 In 2005, Zheng et al. administered crocetin, the natural carotenoid antioxidant, to rabbits to determine its effect on the development of atherosclerosis. The authors randomly assigned New Zealand white rabbits to three different diets for eight weeks: a standard diet, a high lipid diet (HLD), or a high lipid + crocetin diet. The HLD group developed hypercholesterolemia and atherosclerosis, while the crocetin-supplemented group decreased the negative health effects of a high lipid diet.13 The results did not show a significant difference in the plasma lipid levels (total, low density lipoprotein (LDL), and high density lipoprotein (HDL) cholesterol) between the HLD and crocetin groups but did show a significant decrease in the aorta cholesterol deposits, atheroma, foam cells, and atherosclerotic lesions in the crocetin-fed group. They suggested that nuclear factor kappa B (NF-κB) activation in the aortas is suppressed by antioxidants such as crocetin which in turn decreases the vascular cell adhesion molecule-1 (VCAM-1) expression.13 A 2006 study by Sheng and colleagues looked at an alternative mechanism for crocin’s atherosclerotic properties.14 Crocin inhibited an increase in serum triglycerides, total-, LDL-, cholesterol compared to the control group as seen before; however, the results also showed a significant increase in the fecal excretion of fat and cholesterol in the crocin group (100 mg/kg/day).14 Further studies determined that crocin inhibited pancreatic and gastric lipase activity, although a potential mechanism was not offered. Since pancreatic lipase is responsible for fat absorption by hydrolyzing fat, the inhibition of pancreatic lipase activity resulted in low lipid absorption. With a lack of potential pancreatic lipase inhibitors available, crocin shows promise as a drug for treating hyperlipidemia.14 In conclusion, saffron helps reduce the risk of heart diseases by strengthening the blood circulatory system. Rich in minerals like thiamin and riboflavin, saffron promotes a healthy heart and prevents different cardiac problems.
  12 in total

1.  Suppression of vascular cell adhesion molecule-1 expression by crocetin contributes to attenuation of atherosclerosis in hypercholesterolemic rabbits.

Authors:  Shuguo Zheng; Zhiyu Qian; Futian Tang; Liang Sheng
Journal:  Biochem Pharmacol       Date:  2005-10-15       Impact factor: 5.858

2.  Crocus sativus L. (petal) in the treatment of mild-to-moderate depression: a double-blind, randomized and placebo-controlled trial.

Authors:  Esmail Moshiri; Afshin Akhondzadeh Basti; Ahamad-Ali Noorbala; Amir-Hossein Jamshidi; Seyed Hesameddin Abbasi; Shahin Akhondzadeh
Journal:  Phytomedicine       Date:  2006-09-18       Impact factor: 5.340

3.  Comparison of petal of Crocus sativus L. and fluoxetine in the treatment of depressed outpatients: a pilot double-blind randomized trial.

Authors:  Afshin Akhondzadeh Basti; Esmail Moshiri; Ahamad-Ali Noorbala; Amir-Hossein Jamshidi; Seyed Hesameddin Abbasi; Shahin Akhondzadeh
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2006-12-15       Impact factor: 5.067

4.  Mechanism of hypolipidemic effect of crocin in rats: crocin inhibits pancreatic lipase.

Authors:  Liang Sheng; Zhiyu Qian; Shuguo Zheng; Liang Xi
Journal:  Eur J Pharmacol       Date:  2006-06-02       Impact factor: 4.432

5.  Saffron in the treatment of patients with mild to moderate Alzheimer's disease: a 16-week, randomized and placebo-controlled trial.

Authors:  S Akhondzadeh; M Shafiee Sabet; M H Harirchian; M Togha; H Cheraghmakani; S Razeghi; S Sh Hejazi; M H Yousefi; R Alimardani; A Jamshidi; F Zare; A Moradi
Journal:  J Clin Pharm Ther       Date:  2010-10       Impact factor: 2.512

6.  Crocus sativus L. in the treatment of mild to moderate depression: a double-blind, randomized and placebo-controlled trial.

Authors:  Shahin Akhondzadeh; Najaf Tahmacebi-Pour; Ahamad-Ali Noorbala; Homayoun Amini; Hassan Fallah-Pour; Amir-Hossein Jamshidi; Mousa Khani
Journal:  Phytother Res       Date:  2005-02       Impact factor: 5.878

7.  Hydro-alcoholic extract of Crocus sativus L. versus fluoxetine in the treatment of mild to moderate depression: a double-blind, randomized pilot trial.

Authors:  A A Noorbala; S Akhondzadeh; N Tahmacebi-Pour; A H Jamshidi
Journal:  J Ethnopharmacol       Date:  2005-01-06       Impact factor: 4.360

8.  A 22-week, multicenter, randomized, double-blind controlled trial of Crocus sativus in the treatment of mild-to-moderate Alzheimer's disease.

Authors:  Shahin Akhondzadeh; Mehdi Shafiee Sabet; Mohammad Hossein Harirchian; Mansoreh Togha; Hamed Cheraghmakani; Soodeh Razeghi; Seyyed Shamssedin Hejazi; Mohammad Hossein Yousefi; Roozbeh Alimardani; Amirhossein Jamshidi; Shams-Ali Rezazadeh; Aboulghasem Yousefi; Farhad Zare; Atbin Moradi; Ardalan Vossoughi
Journal:  Psychopharmacology (Berl)       Date:  2009-10-20       Impact factor: 4.530

9.  Crocus sativus L. (saffron) in the treatment of premenstrual syndrome: a double-blind, randomised and placebo-controlled trial.

Authors:  M Agha-Hosseini; L Kashani; A Aleyaseen; A Ghoreishi; H Rahmanpour; A R Zarrinara; S Akhondzadeh
Journal:  BJOG       Date:  2008-03       Impact factor: 6.531

10.  Antioxidant property of Saffron in man.

Authors:  S K Verma; A Bordia
Journal:  Indian J Med Sci       Date:  1998-05
View more
  15 in total

1.  Identification of bacteria associated with underground parts of Crocus sativus by 16S rRNA gene targeted metagenomic approach.

Authors:  Sheetal Ambardar; Naseer Sangwan; A Manjula; J Rajendhran; P Gunasekaran; Rup Lal; Jyoti Vakhlu
Journal:  World J Microbiol Biotechnol       Date:  2014-07-03       Impact factor: 3.312

Review 2.  A systematic review of randomized controlled trials examining the effectiveness of saffron (Crocus sativus L.) on psychological and behavioral outcomes.

Authors:  Heather Ann Hausenblas; Kacey Heekin; Heather Lee Mutchie; Stephen Anton
Journal:  J Integr Med       Date:  2015-07

Review 3.  Saffron as a promising therapy for diabetes and Alzheimer's disease: mechanistic insights.

Authors:  Sarvin Sanaie; Saba Nikanfar; Zahra Yousefi Kalekhane; Akbar Azizi-Zeinalhajlou; Saeed Sadigh-Eteghad; Mostafa Araj-Khodaei; Mohammad Hossein Ayati; Sasan Andalib
Journal:  Metab Brain Dis       Date:  2022-08-20       Impact factor: 3.655

4.  The Association of Cigarette Smoke Exposure with Lung Cellular Toxicity and Oxidative Stress: the Protective Role of Crocin.

Authors:  Maryam Radan; Mahin Dianat; Mohammad Badavi; Seyyed Ali Mard; Vahid Bayati; Masoumeh Ahmadizadeh
Journal:  Inflammation       Date:  2020-02       Impact factor: 4.092

Review 5.  Saffron: A Natural Potent Antioxidant as a Promising Anti-Obesity Drug.

Authors:  Maryam Mashmoul; Azrina Azlan; Huzwah Khaza'ai; Barakatun Nisak Mohd Yusof; Sabariah Mohd Noor
Journal:  Antioxidants (Basel)       Date:  2013-10-29

6.  Proteomic screening of molecular targets of crocin.

Authors:  Hossein Hosseinzadeh; Soghra Mehri; Ali Heshmati; Mohammad Ramezani; Amirhossein Sahebkar; Khalil Abnous
Journal:  Daru       Date:  2014-01-06       Impact factor: 3.117

Review 7.  Dietary agents and phytochemicals in the prevention and treatment of experimental ulcerative colitis.

Authors:  Arpit Saxena; Kamaljeet Kaur; Shweta Hegde; Faizan M Kalekhan; Manjeshwar Shrinath Baliga; Raja Fayad
Journal:  J Tradit Complement Med       Date:  2014-10

8.  Systems pharmacology analysis of synergy of TCM: an example using saffron formula.

Authors:  Jianling Liu; Jingjing Liu; Fengxia Shen; Zonghui Qin; Meng Jiang; Jinglin Zhu; Zhenzhong Wang; Jun Zhou; Yingxue Fu; Xuetong Chen; Chao Huang; Wei Xiao; Chunli Zheng; Yonghua Wang
Journal:  Sci Rep       Date:  2018-01-10       Impact factor: 4.379

9.  Evaluation of lung and bronchoalveolar lavage fluid oxidative stress indices for assessing the preventing effects of safranal on respiratory distress in diabetic rats.

Authors:  Saeed Samarghandian; Reza Afshari; Aghdas Sadati
Journal:  ScientificWorldJournal       Date:  2014-02-20

10.  The Efficacy of Crocin of Saffron (Crocus sativus L.) on the Components of Metabolic Syndrome: A Randomized Controlled Clinical Trial.

Authors:  Tayyebe Kermani; Toba Kazemi; Somayye Molki; Khadije Ilkhani; Gholamreza Sharifzadeh; Omid Rajabi
Journal:  J Res Pharm Pract       Date:  2017 Oct-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.